Ticker: KEYS

Keysight Technologies

Semiconductors Technology Hardware, Equipment & Parts
Price 327.41
Reco Buy Potential 69 Risk 39 Updated 2026-09-10

Forecast impact

positive
Target +28.4% target fill 77.9%
Reaction D5 -1.96% · D10 +0.19% market trust
Impact Potential +3 · Risk -1 valid until 2026-09-18

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Keysight Technologies provides electronic design and test solutions for various industries, including telecommunications, aerospace, defense, automotive, and semiconductor sectors. Its core products include software and hardware for network testing, signal analysis, and electronic measurement. Major business segments encompass communications solutions, electronic industrial solutions, and automated test solutions, with primary revenue sources derived from product sales and software licenses.

Investment Profile

The investment profile of Keysight Technologies is more aligned with growth investors due to its strong revenue growth and potential for innovation in technology solutions. The company demonstrates solid performance metrics, making it suitable for those seeking capital appreciation.

Fundamental metrics (experimental) Updated: 2026-09-07
EPS (TTM) — earnings per share for the last 12 months, $
7.26
Revenue QoQ — quarter-over-quarter revenue growth
7.5%
EPS surprise
23.8%
20d volatility
2.2%
AI recommendation changes
Date Before After Reason
2026-08-27 Hold Buy Strong fundamentals, but mixed momentum signals.
2026-08-20 Buy Hold Weak momentum and high risk; cautious approach advised.
2026-08-06 Hold Buy Strong fundamentals but mixed momentum signals.
Analyst forecasts
Date Analyst Action Target Price Then
2026-08-19 Morgan Stanley Target Raised 400 → 425 319.23499
2026-08-19 UBS Target Raised 420 → 440 323.15
2026-08-19 Truist Financial Target Raised 376 → 400 341.3
News Page 1 of 1
Mercury Systems La-Z-Boy Estee Lauder Lowe's Companies Analog Devices Toll Brothers Keysight Technologies Merck Moderna

Stocks to Watch: Moderna and Merck Surge on Positive Cancer Vaccine Trial Results, While Lowe’s and La-Z-Boy Face Declines

Moderna and Merck's shares surged following positive results from a late-stage trial of their personalized cancer vaccine, while other companies like Keysight Technologies and Estee Lauder reported strong earnings, impacting their stock prices positively. Conversely, Lowe's and La-Z-Boy faced declines due to disappointing forecasts and earnings results.
MDU Resources NIO Capital One Keysight Technologies Deckers Outdoor Atmos Energy American Express Tesla Shopify

Analysts Jefferies raised Tesla (TSLA) target price to $400, while JPMorgan upgraded American Express (AXP) to overweight

Several significant analyst upgrades and downgrades were announced, impacting various companies across sectors, with notable adjustments for Tesla, American Express, and Nio, among others. These changes reflect analysts' confidence in certain stocks amid current market conditions.